NLS Pharmaceutics
NLSP
NLSP
7 hedge funds and large institutions have $4.35M invested in NLS Pharmaceutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
7
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$140K | |
| 2 | -$40.8K | |
| 3 | -$23.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.75K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$110 |